DPYSL2 and Hyperglycemia: We conclude that hyperglycemia leads to enhanced cell proliferation and cytoskeleton flexibility via promoting actin de-polymerization, and thus endows CRC cells with higher metastatic potential by downregulating CRMP2 profile and contributes to CRC disease progression.